Portfolio company
Ascendis Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
Digital Health
About
This biopharmaceutical company develops long-acting prodrug therapies for patients with rare endocrine diseases and cancer using its proprietary drug delivery technology.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.